Udg Healthcare could regain its upward trend after having ran out of steam.

The group is still undervalued and the “enterprise value to sales” ratio shows an attractive valuation of 0.84x for the current year. The share quote displays a great upward potential to reach the consensus average target price. The company's Surperformance rating underlines the positive revenue estimates revisions and the attractive valuation.

Udg Healthcare is in an uptrend in the medium and long term. Nevertheless, a recent decline should brought back the stock in the GBp 470’s support area. Weekly moving averages remain well oriented and indicators show an oversold situation.
Consequently, investors may open a long position in the support zone and target a reversal toward the GBp 508 resistance. A stop loss order should be set at GBp 459.